Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

SEMA / IGF-1 LR3Interpret the evidence

Why the bimagrumab and semaglutide trial belongs to its exact combination

2 numbered sourcesSource years 1992, 2026

Peptides are short chains of amino acids joined by peptide bonds. Some serve as hormone signals and some can be used to test how one pathway interacts with another. Semaglutide is a peptide that activates the GLP-1 receptor. IGF-1 LR3 is an engineered growth-factor protein. A 2026 randomized trial tested semaglutide with a different add-on, the investigational antibody bimagrumab. The trial shows how investigators separated the effects of the actual components they studied. [1, 2]

Bimagrumab targets type II activin receptors, part of a signaling system involved in regulating tissue growth. The researchers randomized 507 adults to nine groups. The groups included placebo, semaglutide alone, bimagrumab alone and different combinations of the two. This structure allowed researchers to compare individual interventions and the combined treatment within the same trial. [1]

The main outcome was change in absolute body weight after 48 weeks. The paper reported reductions with both single components and the combination, and also reported adverse events. The authors described different types of commonly reported events for each component, including muscle spasms with bimagrumab and nausea with semaglutide. Those patterns matter because the experience with two active substances may differ from the experience with either one individually. [1]

IGF-1 LR3 is a modified growth factor, while bimagrumab is an antibody against a different receptor system. A result from the bimagrumab combination does not reveal the benefit or risk of adding IGF-1 LR3. The useful lesson from the trial is its design. Direct evidence for a second agent comes from comparing groups that actually received that agent, with and without the other component as appropriate. [1, 2]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop SEMA / IGF-1 LR3

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.